Obstetrics & Gynecology

Medicine & Life Sciences

1. Pre-Eclampsia 100%
2. Pregnancy 95%
3. Japan 74%
4. Uterine Cervical Neoplasms 64%
5. Placenta 54%
6. Mothers 51%
7. Endometrial Neoplasms 49%
8. Neoplasms 45%
9. Uterine Neoplasms 41%
10. Obstetrics 41%
11. Trachelectomy 39%
12. Cervical Intraepithelial Neoplasia 37%
13. Multicenter Studies 37%
14. Ovarian Neoplasms 35%
15. Genes 34%
16. Indoleamine-Pyrrole 2,3,-Dioxygenase 29%
17. Cervix Mucus 28%
18. Fetal Growth Retardation 27%
19. Fallopian Tubes 27%
20. Noninvasive Prenatal Testing 25%
21. Gynecology 25%
22. Trophoblasts 24%
23. Ovary 24%
24. Pregnant Women 23%
25. Paclitaxel 23%
26. Retrospective Studies 22%
27. Cervix Uteri 21%
28. Conization 21%
29. Congenital Diaphragmatic Hernias 20%
30. Carboplatin 20%
31. Drug Therapy 20%
32. Sizofiran 19%
33. nedaplatin 19%
34. Laparoscopy 19%
35. Cyclooxygenase 2 Inhibitors 19%
36. Adenocarcinoma 17%
37. Genetic Testing 17%
38. Breast Neoplasms 17%
39. Postpartum Period 17%
40. Extremely Premature Infants 17%
41. Serum 17%
42. Proteins 16%
43. Vaginal Neoplasms 16%
44. Cell-Free Nucleic Acids 15%
45. Therapeutics 15%
46. Neoplasm Metastasis 15%
47. Genotype 15%
48. liposomal doxorubicin 15%
49. High-Throughput Nucleotide Sequencing 15%
50. Body Mass Index 14%
51. Female Infertility 14%
52. Etodolac 14%
53. Endometrioid Carcinoma 14%
54. Assisted Reproductive Techniques 14%
55. Genetic Counseling 14%
56. Lymph Node Excision 13%
57. Postpartum Depression 13%
58. MicroRNAs 13%
59. Premature Birth 13%
60. Everolimus 13%
61. Squamous Intraepithelial Lesions 13%
62. Platinum 13%
63. Hysterectomy 13%
64. Mutation 13%
65. Messenger RNA 13%
66. Parturition 12%
67. Laparotomy 12%
68. Estrogens 12%
69. Up-Regulation 12%
70. Infertility 12%
71. Pregnancy Rate 12%
72. DNA Repair 12%
73. Synaptonemal Complex 12%
74. Machine Learning 12%
75. Annexin A5 12%
76. Spontaneous Abortion 12%
77. Bevacizumab 12%
78. Immunohistochemistry 11%
79. Recurrence 11%
80. Premature Infants 11%
81. Cyclooxygenase 2 11%
82. Aneuploidy 11%
83. Prospective Studies 10%
84. Protein Phosphatase 2 10%
85. nitrofen 10%
86. Ultrasonography 10%
87. Polymerase Chain Reaction 10%
88. Haplotypes 10%
89. Blood Pressure 10%
90. Adjuvant Chemotherapy 10%
91. Clear Cell Adenocarcinoma 10%
92. Survival 10%
93. Cytokines 10%
94. Follistatin-Related Proteins 10%
95. Lymph Nodes 9%
96. Biomarkers 9%
97. LY 165163 9%
98. Salpingo-oophorectomy 9%
99. prorenin receptor 9%
100. Fertility 9%